Zygomycosis
ICD-10 B46 is a billable code used to indicate a diagnosis of zygomycosis.
Zygomycosis, also known as mucormycosis, is a severe fungal infection caused by a group of molds called mucormycetes. These fungi are commonly found in soil, decaying fruits, and vegetables. Zygomycosis primarily affects individuals with weakened immune systems, such as those with uncontrolled diabetes, cancer, or those undergoing immunosuppressive therapies. The infection can manifest in various forms, including rhinocerebral, pulmonary, and disseminated zygomycosis. Symptoms may include facial swelling, nasal congestion, fever, cough, and chest pain, depending on the site of infection. Diagnosis is typically made through clinical evaluation, imaging studies, and microbiological cultures. Treatment involves aggressive antifungal therapy, often with amphotericin B, and surgical debridement of necrotic tissue. Early diagnosis and intervention are critical for improving outcomes, especially in immunocompromised patients, where the mortality rate can be significantly high.
Detailed clinical notes on patient history, immunocompromised status, and treatment response.
Patients presenting with respiratory symptoms and a history of diabetes or recent chemotherapy.
Ensure clear documentation of the type of zygomycosis and any comorbid conditions.
Pulmonary function tests, imaging studies, and detailed symptom descriptions.
Patients with pulmonary zygomycosis presenting with cough and chest pain.
Document any prior lung conditions that may complicate the diagnosis.
Used when surgical debridement is performed for zygomycosis.
Pathology report and clinical notes detailing the procedure.
Ensure that the pathology report clearly indicates the diagnosis of zygomycosis.
Common symptoms include facial swelling, nasal congestion, fever, cough, and chest pain, depending on the site of infection.
Treatment typically involves antifungal medications such as amphotericin B and may require surgical debridement of infected tissue.
